DK0542807T3 - Use of 2-phenyl-1,2-benzisoselenazol-3 (2H) -one - Google Patents

Use of 2-phenyl-1,2-benzisoselenazol-3 (2H) -one

Info

Publication number
DK0542807T3
DK0542807T3 DK91914052T DK91914052T DK0542807T3 DK 0542807 T3 DK0542807 T3 DK 0542807T3 DK 91914052 T DK91914052 T DK 91914052T DK 91914052 T DK91914052 T DK 91914052T DK 0542807 T3 DK0542807 T3 DK 0542807T3
Authority
DK
Denmark
Prior art keywords
benzisoselenazol
phenyl
ebselen
cisplatin
reducing
Prior art date
Application number
DK91914052T
Other languages
Danish (da)
Inventor
Glenn S Baldew
N P E Vermeulen
Original Assignee
Rhone Poulenc Rorer Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Gmbh filed Critical Rhone Poulenc Rorer Gmbh
Application granted granted Critical
Publication of DK0542807T3 publication Critical patent/DK0542807T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

2-Phenyl-1,2-benzisoselenazol-3(2H)-one(Ebselen) is capable of reducing the cisplatin-induced nephrotoxicity and neurotoxicity during cytostatic treatment.
DK91914052T 1990-08-06 1991-07-31 Use of 2-phenyl-1,2-benzisoselenazol-3 (2H) -one DK0542807T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4024885A DE4024885C2 (en) 1990-08-06 1990-08-06 Use of 2-phenyl-1,2-benzisoselenazol-3 (2H) -one
PCT/EP1991/001438 WO1992002221A1 (en) 1990-08-06 1991-07-31 Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one

Publications (1)

Publication Number Publication Date
DK0542807T3 true DK0542807T3 (en) 1999-06-21

Family

ID=6411708

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91914052T DK0542807T3 (en) 1990-08-06 1991-07-31 Use of 2-phenyl-1,2-benzisoselenazol-3 (2H) -one

Country Status (8)

Country Link
EP (1) EP0542807B1 (en)
JP (1) JP3084062B2 (en)
AT (1) ATE171621T1 (en)
CA (1) CA2088760C (en)
DE (2) DE4024885C2 (en)
DK (1) DK0542807T3 (en)
ES (1) ES2123510T3 (en)
WO (1) WO1992002221A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2553434B2 (en) * 1992-04-28 1996-11-13 第一製薬株式会社 Granular formulation
US6335036B1 (en) 1993-10-27 2002-01-01 Daiichi Pharmaceutical Co., Ltd. Granular pharmaceutical preparation of ebselen
EP0826370B1 (en) * 1996-08-27 2002-06-19 A. Nattermann & Cie. GmbH Pharmaceutical composition comprising 2-phenyl-1,2-benzoisoelenazol-3(2H)-one for the treatment of Alzheimer disease
DE19825746A1 (en) * 1998-06-09 1999-12-16 Biosyn Arzneimittel Gmbh Combination of selenium-containing compounds with cytostatics
CN1166651C (en) * 2001-06-08 2004-09-15 北京大学药学院 Anti-inflammatory and antineoplastic R-bis or glycophenylpropane isoselenazole substituted compound
WO2003026570A2 (en) * 2001-09-24 2003-04-03 Tosk, Inc. Reduced toxicity cisplatin formulations and methods for using the same
US20030157191A1 (en) * 2001-11-29 2003-08-21 Sound Pharmaceuticals Incorporated Methods and compositions for ameliorating the undesirable effects of chemotherapy
ES2497716T3 (en) 2002-01-04 2014-09-23 Sound Pharmaceuticals Incorporated Compositions for use in methods intended to treat hearing loss
US20060211745A1 (en) * 2005-03-08 2006-09-21 Sound Pharmaceuticals Incorporated Methods and compositions for treating cancer
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (en) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmaceutical preparations containing 2-phenyl-1,2-benzisoselenazol-3 (2H) -one
DE3616923A1 (en) * 1986-05-20 1987-11-26 Nattermann A & Cie NEW PHARMACEUTICAL USE OF 2-PHENYL-1,2-BENZISOSELENAZOLE-3 (2H) -ON
DE3638124C2 (en) * 1986-11-08 1996-09-05 Nattermann A & Cie New pharmaceutical use of Ebselen
DE3821392A1 (en) * 1988-06-24 1989-12-28 Nattermann A & Cie NEW PHARMACEUTICAL USE OF 2-PHENYL-1,2-BENZISOSELENAZOLE-3 (2H) -ONEONE (EBSELEN)

Also Published As

Publication number Publication date
WO1992002221A1 (en) 1992-02-20
DE4024885A1 (en) 1992-02-13
ES2123510T3 (en) 1999-01-16
ATE171621T1 (en) 1998-10-15
EP0542807B1 (en) 1998-09-30
EP0542807A1 (en) 1993-05-26
CA2088760C (en) 2002-05-07
DE4024885C2 (en) 2002-07-18
JP3084062B2 (en) 2000-09-04
DE69130292T2 (en) 1999-04-08
CA2088760A1 (en) 1993-02-01
JPH05509309A (en) 1993-12-22
DE69130292D1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
HUP0000369A2 (en) 3-thiocarbamoylpyrazole derivatives and their use as pesticides
FI925211A (en) ISOXAZOL-4-CARBOXYLSYRAMIDER OCH HYDROXIALKYLIDENCYANAETHXYRAMIDER, CEILING MODEL INNEHAOLLANDE DESSA OCH ANVAENDNING AV DESSA
DK0509019T3 (en) Treatment of human retroviral infections with 2 ', 3'-dideoxyinosine
DK0765327T3 (en) Pyrazolo and pyrrolopyridines
DK0542807T3 (en) Use of 2-phenyl-1,2-benzisoselenazol-3 (2H) -one
SE9101815D0 (en) TREATMENT OF DISEASES ASSOCIATED WITH HIV INFECTIONS
ES465173A1 (en) 2-Substituted benzisothiazolones
DE69825605D1 (en) TREATING SCHIZOPHRENIA AND PSYCHOSIS
DK278788A (en) ostomy
DE60128100D1 (en) ANALGICAL DRUG
NO993360D0 (en) Use of pramipexole in the treatment of the "restless leg" syndrome
NO894281D0 (en) STABLE PARENTERAL SOLUTIONS OF 2-PHENYL-1,2-BENZISOSELENAZOL-3 (H) -ON AND PROCEDURE FOR THE PREPARATION OF THE SAME.
DE69015344T2 (en) Phosphate compositions, sintered body thereof and manufacture of this sintered body.
SE8304545D0 (en) BENZAMIDE DERIVATIVES
DE59106803D1 (en) Substituted pyrido-oxazines.
MXPA03002914A (en) Hexahydropyrazino `1 2 : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction.
ATE5144T1 (en) THIAZOLE DERIVATIVES, THEIR PRODUCTION AND THERAPEUTIC USE.
TR199801902A2 (en) Chromans substituted with sulfonamides, pharmacological compositions containing them.
DK0869813T3 (en) Use of beta interferons for the treatment of restenosis
DE69731407D1 (en) ABSORBENT ARTICLES WITH MEANS TO REACH AND KEEP CONVEX-CONCAVE ARCHES
TR200003084T2 (en) Paroxetine ascorbate
DK177191D0 (en) HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE
SU1016983A1 (en) 3-Substituted 6,8-dimethylpyrimido- [5,4-e] [1,2,4] -triazin-5,7-dione, showing anti-inflammatory and antimicrobial activity
SU1602007A1 (en) 6- (4,5-Diphenylthienyl-2) -3-thia-1,2,4-triazin-5-one, showing anti-inflammatory and antimicrobial activity
ES1005154U (en) Cookie (Machine-translation by Google Translate, not legally binding)